AstraZeneca start recall COVID-19 vaccines available worldwide

AstraZeneca A global recall of COVID-19 vaccines has begun due to more vaccines than needed since the start of the COVID-19 pandemic.

On May 8, 2024, Reuters reported that AstraZeneca, a major British-Swedish pharmaceutical company, said it had begun recalling its COVID-19 vaccine globally due to an oversupply of vaccines since the start of the pandemic.

AstraZeneca It also said it would revoke the marketing authorization of the Vaxzevria vaccine in Europe.

“Since multiple variants of the COVID-19 vaccine have been developed, there is a surplus of improved vaccines available,” the company said, adding that this has resulted in decreased demand for the Vaxseveria vaccine, which is no longer produced or supplied.

AstraZeneca applied to withdraw the vaccine on March 5, and it came into effect on May 7, according to the Telegraph. which first reported the development

AstraZeneca It began manufacturing vaccines against respiratory viral infections and anti-obesity drugs through several deals last year. This comes after a slowdown in growth due to falling sales of COVID-19 drugs.

Reference: reuters.com

📌 Read all news related to the global economic situation here 📌